Abstract
Depression of cell-mediated immune reactions during viral infection has been a repeatedly confirmed phenomenon since the original observation of von Pirquet (20). Reports have included depression of tuberculin activity in man following viral infection or vaccination (2,3,12,16,19) as well as prolongation of allograft survival in virus-infected mice (14). Numerous investigations have indicated that virus-induced Type I interferons can modulate cell-mediated immune responses. These also include inhibition of the development of delayed-type hypersensitivity to tuberculin and sheep red blood cells (6,7) and prolongation of skin allograft survival in mice (13).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
